Literature DB >> 7735910

Cholecystokinin does not act on the efferent pathway of cholinergic and adrenergic nerves to inhibit ruminal contractions in sheep (Ovis aries).

T Onaga1, T Onodera, H Mineo, S Kato.   

Abstract

The effect of exogenous cholecystokinin-octapeptide (CCK-8) on ruminal contractions and the role of efferent pathways of cholinergic and adrenergic nerves on the effect were studied in sheep. Intravenous infusion of CCK-8 at 11.4 and 45.6 pmol/kg/min significantly inhibited the frequency and amplitude of ruminal contractions in conscious sheep. After bilateral cervical vagotomy, intravenous infusion of CCK-8 at 45.6 mol/kg/min had no detectable effect on amplitude of ruminal contractions induced by electric stimulation to the cervical vagus nerve (1 msec, 20 Hz, 5 mA, for 10 sec at 1-min intervals) in anesthetized sheep. The amplitude of contractile responses of ovine ruminal muscle strips to acetylcholine at 5 x 10(-5) M was not inhibited by CCK-8 applied simultaneously at 1 x 10(-9) M. Intravenous infusion of phentolamine at 53.0 nmol/kg/min, propranolol at 101.4 nmol/kg/min, or their combined infusion did not alter the inhibitory action of CCK-8 at either dose on ruminal contractions in conscious sheep. These results suggest that CCK-8, which does not act on the efferent pathway of cholinergic and adrenergic nerves, may reflexively inhibit reticuloruminal contractions via vagal afferent fibers in sheep.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7735910     DOI: 10.1016/0300-9629(95)98519-m

Source DB:  PubMed          Journal:  Comp Biochem Physiol A Physiol        ISSN: 1096-4940


  2 in total

1.  Effect of intravenous infusion of proglumide on ruminal motility in conscious sheep (Ovis aries).

Authors:  T Onaga
Journal:  Vet Res Commun       Date:  2007-02-05       Impact factor: 2.816

2.  Effects of ginger extract on smooth muscle activity of sheep reticulum and rumen.

Authors:  Amin Mamaghani; Masoud Maham; Bahram Dalir-Naghadeh
Journal:  Vet Res Forum       Date:  2013       Impact factor: 1.054

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.